Skip to main content
. 2026 Mar 9;18(3):337. doi: 10.3390/pharmaceutics18030337
AI artificial intelligence
BCG Bacillus Calmette–Guérin
CagA cytotoxin-associated gene A
CMC Chemistry Manufacturing and Controls
COX-2 cyclooxygenase-2
CQAs critical quality attributes
DDS drug delivery systems
ECM extracellular matrix
EGF epidermal growth factor
EGFR epidermal growth factor receptor
EMR Eradicate-Modulate-Regenerate
EPS extracellular polymeric substances
GRDDS gastro-retentive drug delivery systems
GRT gastric residence time
HDDT high-dose dual therapy
HIF hypoxia-inducible factor
HO-1 heme oxygenase-1
IFN-γ interferon-γ
IL-10 interleukin-10
MHC major histocompatibility complex
MIC minimum inhibitory concentration
miRNAs microRNAs
MOFs metal–organic frameworks
MSNs mesoporous silica nanoparticles
NF-κB nuclear factor kappa B
NLCs nanostructured lipid carriers
Nrf2 nuclear factor erythroid 2-related factor 2
PHD prolyl hydroxylase domain
PDT photodynamic therapy
PPIs proton pump inhibitors
PTT photothermal therapy
QbD quality by design
RCTs randomized controlled trials
ROS reactive oxygen species
RNS reactive nitrogen species
RR risk ratio
RWE real-world evidence
SCFAs short-chain fatty acids
SOD superoxide dismutase
TFFs trefoil factor family
TFF2 trefoil factor 2
TGF-β transforming growth factor-β
TJs tight junctions
TLRs toll-like receptors
TLR4 Toll-like receptor 4
TNF-α tumor necrosis factor-α
Tregs regulatory T cells
Th1 T helper 1
Th17 T helper 17
TSG-6 tumor necrosis factor-stimulated gene-6
VacA vacuolating cytotoxin A.